Allen James Meglin, Director at Organicell Regenerative Medicine, Inc. (BPSR), bought 12,016,666 shares at $0.02 ($252K) on 2020-05-22, disclosed to the SEC on 2020-08-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.02 | 3,500,000 | $70K | 27.8% |
| 2 | $0.02 | 1,350,000 | $27K | 10.7% |
| 3 | $0.02 | 1,000,000 | $20K | 7.9% |
| 4 | $0.02 | 2,500,000 | $50K | 19.8% |
| 5 | $0.02 | 2,500,000 | $50K | 19.8% |
| 6 | $0.03 | 1,166,666 |
| $35K |
| 13.9% |
| Total | $0.02 avg | 12,016,666 | $252K | 100% |
| Filing → |